Andrew Mayer was Promoted as Senior Vice President and Deputy General Counsel at Acorda

Date of management change: November 12, 2019 

What Happened?

Ardsley, -based Acorda Promoted Andrew Mayer as Senior Vice President and Deputy General Counsel

 

About the Company

Acorda Therapeutics is a publicly traded (NASDAQ: ACOR) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. We started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. We have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. We achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment Acorda has been voted one of the best companies to work for in New York for the past five years in a row, as a result of our dynamic environment, strong corporate culture, significant emphasis on research and development, and a robust product pipeline. We are positioned to be an industry leader, poised for exceptional growth.

 

About the Person

Andrew Mayer is Senior Vice President and Deputy General Counsel at Acorda. Previously, Andrew held various senior legal leadership roles in the industry.

 

Info Source

News

 
 

Other IT executives who recently changed jobs as well: Sullivan Lori, Freeman-Bosworth Lauren, Renaud Kymberly, Sampson Evan, Castillo Frances, Katz Michael, Schinke Emelia, Shah Megha, Thomas Scott, Grawemeyer David, Barnes-Euresti Norma

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.